![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, August 29, 2021 11:52:24 AM
Everyone complains Mc doesn't communicate. When he does, what he can, we get your response.
Send him a message, get your questions answered.
No one that reads this board believes you have made any form of a compelling argument with supported points to agree with your assessment of the BO. You don't factor in competition, the real cost/price of time-value-of-ip, previous share price escalation as witnessed by those that formerly owned ISRG, the cost to develop a RAS SP from the IP that has been licensed to the final product, risk of developing an RAS SP from 15-16 patents to other parts of the device to make it safe, and medically certifiable, other RAS BO's.
You're not in the same galaxy.
Try again.
Good luck to all. Regards,BK.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM